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Background: Airway liquid hyper-absorption is a key pathophysiological link between the genetic mutations of
cystic fibrosis (CF) and the development of lung disease. Here we consider whether the clearance of radiolabeled
diethylene triamine pentaacetic acid (DTPA) might be used to detect changes in airway liquid absorption.
Methods: Tc99m-DTPA was added to the apical (luminal) surface of primary human bronchial epithelial cell
cultures from CF and non-CF lungs. Liquid absorption rates were assessed using an optical method and compared
to DTPA absorption rates. Measurements of transepithelial electrical resistance (TER) were made to determine the
effect of epithelial permeability. DTPA absorption was assessed after stimuli known to influence liquid absorption
(volume addition and osmotic gradients) and in cultures containing different proportions of CF and non-CF cells.
Results: DTPA absorption rate was increased in CF cultures matching previous in vivo studies in individuals with CF.
DTPA and liquid absorption rates were proportional. There was no relationship between TER and DTPA absorption
rate when measured in individual cultures. Apical volume addition increased both DTPA and liquid absorption rates.
DTPA absorption increased in a dose-dependent manner after basolateral mannitol addition was used to create
transepithelial osmotic gradients favoring liquid absorption. Conversely, apical mannitol (a candidate therapy)
slowed DTPA absorption in CF cultures.
Conclusions: These results imply that DTPA absorption is directly related to liquid absorption, consistent with
increased rates of airway surface liquid absorption in the CF airway, and that modification of liquid absorption from
osmotic therapies might be detectable through DTPA absorption measurements in vivo.
Trial registration: none
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Cystic fibrosis (CF) is an autosomal recessive disease
associated with a single gene - the cystic fibrosis trans-
membrane conductance regulator (CFTR). Defective
function of the epithelial sodium channel (ENaC) also
appears to play a key role [1,2]. By controlling Cl− and
Na+ transport across the apical surface of epithelial cells,
CFTR and ENaC establish the osmotic gradients that
drive liquid transport across the airway epithelium.
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in any medium, provided the original work is pmucus that lines the airways in order to maintain nor-
mal mucociliary and cough clearance in the lungs. The
basic defect of CF is associated with a failure to conduct
chloride through CFTR. The hyper-absorption of sodium by
ENaC has also been described [2]; however, some recent lit-
erature disputes this effect [3]. An osmotic gradient that
favors the rapid absorption of liquid from the CF airway sur-
face ultimately results in the accumulation of dehydrated
mucus in the airways and the gradual failure of mucociliary
clearance. CF patients become vulnerable to pulmonary in-
fection which leads to inflammation and, eventually, perman-
ent lung damage, significant losses in pulmonary function,
and premature mortality [4-9]. A clinical method for
detecting changes in airway liquid absorption could provide
a means of screening medications designed to correct thes an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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CFTR correctors and potentiators that have been the focus
of recent therapeutic development efforts [10].
Radiolabeled diethylene triamine pentaacetic acid (DTPA)
has been used for pulmonary diagnostic imaging for many
years. Ventilation scans with aerosolized technetium 99m-
labeled DTPA (Tc-DTPA) are commonly performed, and
there is extensive literature on the use of DTPA clearance
as a measure of lung permeability. Increases in DTPA clear-
ance have been associated with pro-inflammatory stimuli,
such as cigarette smoke [11,12], and diseases with inflam-
matory components, such as asthma [13]. Our previous
studies have demonstrated increased rates of DTPA clear-
ance in the lungs of CF patients. Whole-lung clearance
rates in these subjects were increased by 27% compared to
healthy controls. A multi-probe method (indium 111-
DTPA and Tc99m sulfur colloid) was used to estimate the
mucociliary and absorptive elements of DTPA clearance in
these subjects. The absorptive component of DTPA clear-
ance was increased by more than 30% in the airway-
dominated central lung zones in CF [14]. Multiple factors
may influence permeability and the clearance of DTPA
from the lungs. DTPA is a small charged molecule with no
known mechanism for transcellular movement. Tight junc-
tion conditions could therefore substantially influence the
paracellular absorption of DTPA and its ultimate clearance
from the lung. Increases in tight junction diameter by spe-
cific cytokine combinations have been demonstrated and
may explain increased DTPA absorption in the setting of
inflammation [15]. Similarly, the presence of epithelial
damage may provide an alternate route for absorption and
result in increased DTPA clearance [16]. Mucociliary clear-
ance has been shown to contribute to the clearance of
DTPA in the airways [17], and the bronchial circulation rate
has also been shown to affect DTPA clearance [18]. Liquid
transport through the tight junctions could also influence
rates of DTPA absorption. A role for paracellular liquid flux
in determining drug absorption rates in the gut has been
previously described [19], and osmotic gradients across the
epithelium have been shown to substantially influence
DTPA absorption rate [20]. Airway liquid absorption can
occur through both transcellular and paracellular routes.
While the individual contributions of the routes have not
been determined, the transcellular path is thought to dom-
inate in CF [21].
Here we have utilized primary human bronchial epi-
thelial (HBE) cells from CF and non-CF lungs to deter-
mine whether DTPA absorption might provide a useful
gauge of airway liquid absorption. DTPA absorption
rates were measured in HBE cultures and compared to
liquid absorption rates using an optical method for
measuring airway surface liquid (ASL) volume [22].
Mixed-cell cultures including CF and non-CF cells were
used to study how the proportional correction of CFpathophysiology affected sodium and chloride currents
(INa+ and ICl−), transepithelial resistance (TER), DTPA
absorption, and liquid absorption. Measurements of TER
were also performed using a volt-ohm meter to deter-
mine the relative effect of tight junction permeability on
DTPA absorption from individual cell cultures. We also
modulated liquid absorption in the HBE cultures
through the use of apical (luminal) volume addition and
osmotic gradients and examined the effects of these
stimuli on DTPA absorption. Lastly, we assessed the
in vitro response of DTPA absorption to a well-
characterized osmotic therapy using CF HBE cultures.
Methods
Human bronchial epithelial cell model
This model provides an in vitro representation of the
airway epithelium that accurately depicts electrophysi-
ology and CF pathophysiology [21]. Primary HBE cells
were isolated from excess airway tissue dissected from
lungs removed for transplantation. The protocol for col-
lection was approved by the University of Pittsburgh In-
stitutional Review Board. As previously described [23],
the airway sections were digested in a protease solution
overnight to detach the epithelial cells from the tissue.
The cells were then suspended in epithelial growth
media and initially seeded onto sterile tissue culture
flasks pre-coated with human placental collagen. After 5
to 6 days, the cells were seeded onto 0.33-cm2 collagen-
coated transwell filters (0.4-μm pore size, Corning-
Costar Transwell Collagen T-cols, Acton, MA, USA) at
a density of approximately 2 × 106/cm2. When conflu-
ent, the cells were maintained at an air-liquid interface,
and the basolateral media were changed to differenti-
ation media. All cultures utilized in these experiments
were fully differentiated. Each cell line described herein
is from a unique donor. Mixed-cell HBE cultures were
also prepared including different proportions of CF and
non-CF cells. All mixed-cell cultures were prepared from
the same CF and non-CF cell lines in the following
combinations (CF/non-CF): 100%:0%, 95%:5%, 90%:10%,
75%:25%, 50%:50%, and 0%:100%.
Ussing chamber measurements
Ussing chamber measurements of epithelial sodium and
chloride currents (INa+ and ICl−, respectively) and TER
were performed with each cell line utilized in these
experiments, including the mixed-cell cultures. Individ-
ual HBE cultures were mounted on Ussing chambers
(P2300; Physiological Instruments, San Diego, CA,
USA), with custom sliders modified to fit the Transwell
inserts, and were continuously short circuited with an
automatic voltage clamp (VCC MC8, Physiological
Instruments). The bathing Ringer’s solution was
composed of 120 mM NaCl, 25 mM NaHCO3, 3.3 mM
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CaCl2, and 10 mM glucose. Chambers were constantly
gassed with a mixture of 95% O2/5% CO2 at 37°C, which
maintained the pH at 7.4 and established a circulating per-
fusion bath within the Ussing chamber. Transepithelial re-
sistance was recorded by applying a 10-mV pulse per
second via an automated pulse generator. Acquire and
Analyze 2.3 (Physiological Instruments) was used to con-
trol the voltage clamp and analyze short-circuit current
data. Our methods have been previously described in
more detail [23]. The amiloride-sensitive ISC (INa+) was
measured by adding 10 μM amiloride to the apical cham-
ber. Following the addition of amiloride, 10 μM forskolin
was added, and the Cl− current (ICl−) was defined as the
decrease in ISC following the addition of 100 μM
bumetanide to the basolateral surface. Ussing chamber
measurements were also performed to determine the ef-
fect of 300 mM mannitol on TER. Baseline measurements
were made over an approximately 20-min period prior to
the addition of 300 mM mannitol to the apical surface,
after which time measurements were continued for an-
other 20-min period.
DTPA absorption measurements
DTPA absorption was measured from 2 to 24 h after the
addition of 0.37 MBq/ml Tc-DTPA in Ringer's or
phosphate-buffered saline (PBS) solution to the apical
(luminal) surface of the HBE cells. Radioactivity was
measured in the filter containing the epithelial cells and
the ASL by removing it from the media and briefly pla-
cing it in a well counter. Results were decay corrected,
normalized by starting counts, and fit to exponential
curves to generate 24-h percentage clearance rates. We
have previously studied the durability of Tc99m bindingControl
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Figure 1 Optical scanning to measure airway surface liquid volume. (
scanner. As shown in the top panel, non-cystic fibrosis HBE develop a liqui
absent in HBE cultured from cystic fibrosis donors. A magnified view is sho
each individual culture. (B) AUC/ASL volume calibration curve. Increasing v
differentiated HBE cultures, and the area under the curve was measured asto DTPA using paper chromatography (Pinestar Tech-
nology Red strips, Jamestown, PA, USA) with acetone as
a mobile phase to detect free (unbound) 99mTcO4−.
Samples from the mixing vial obtained over 24 h
demonstrated <1% free Tc99m. Samples drawn from the
apical surface of HBE cells over 24 h after the addition
of 10 μL of Tc-DTPA in Ringer’s solution demonstrated
0% to 9% free 99mTcO4−.
An optical method to measure ASL volume
An optical method was used to measure ASL volume
[22]. A meniscus develops at the edge of cultured pri-
mary HBE cells and can be visualized by the graded light
intensity as shown in Figure 1A. Our method utilizes the
refraction pattern induced as transmitted light passes
through that meniscus. Plates containing 12 HBE
cultures were imaged with an optical scanner (Epson
V500, Epson Corporation, Long Beach, CA, USA) and
analyzed using an image analysis algorithm in ImageJ
(NIH, Bethesda, MD, USA). The light intensity across
radial spokes from the center of each filter was
measured, and the area under the curve (AUC) was
calculated. AUC was integrated into an experimentally
determined volume calibration curve as shown in
Figure 1B. The relationship between the ASL volume
and the AUC is robust and linear across volumes of 0 to
20 μL (R2 = 0.97).
Transepithelial electrical resistance measurements
Representative measurements of TER were made in each
of the cell lines used in these studies (via Ussing cham-
ber). TER was also measured in a series of individual cell
cultures on the day prior to measurements of DTPA
absorption, using a volt-ohm meter. Four non-CF linesASL Volume (µL)

















A) Differentiated primary HBE cell cultures were imaged with an optical
d meniscus that surrounds the culture insert. Conversely, this fluid is
wn on the right to demonstrate the liquid meniscus that surrounds
olumes of Ringer’s solution were applied to the apical surface of
described. Data shown are mean AUC vs. applied ASL volume. n = 6.
Corcoran et al. EJNMMI Research 2013, 3:14 Page 4 of 10
http://www.ejnmmires.com/content/3/1/14(30 total cultures) and one CF line (12 cultures) were
included. Cultures were submerged in 550 μL of
Dulbecco’s modified Eagle’s medium (DMEM), and
DMEM was also added to the apical surface (250 μL).
After 15 min, three measurements of TER were made
for each culture using a Millipore Millicell-ERS Volt-
Ohm Meter (Millipore, Billerica, MA, USA). The
DMEM was then aspirated, and the cells were returned
to the media.Figure 2 DTPA absorption rate is increased in epithelial cell
cultures from cystic fibrosis lungs. The mean DTPA absorption
rates in well-differentiated cultures from 9 CF and 11 non-CF primaryEffects of apical liquid volume addition on DTPA and
liquid absorption
The addition of apical liquid volume increases ENaC
current providing a stimulus for liquid absorption [24].
Volumes of 2.5, 5, and 10 μL of Tc-DTPA in Ringer’s so-
lution were added to the apical surface of CF HBE cells
(n = 6 cultures/case). DTPA absorption and apical liquid
volume were then measured over 24 h.cell lines are shown (six filters averaged for each line). Asterisk, p =
0.0013 by t test. Measurements were made after the addition of 10
μL of Tc-DTPA in Ringer’s solution.Effect of transepithelial fluid movement on DTPA
absorption
DTPA absorption rates were measured under different
osmotic gradients across the epithelium. Tc-DTPA in 10
μL of PBS was used. Two CF and two non-CF cell lines
were studied (n = 6 cultures per concentration per line).
Mannitol (150 and 300 mM) was added to the
basolateral media (volume 300 μL). DTPA absorption re-
sponse to 300 mM apical mannitol was also tested to
mimic inhaled therapy in humans [25]. Three CF lines
were included (six cultures per case per line).Statistical methods
Measurements of ICl−, INa+, and TER by Ussing cham-
ber and measurements of DTPA absorption rate in CF
vs. non-CF cells were compared by unpaired t test
(averages by line for 9 CF and 11 non-CF cell lines).
Comparisons of DTPA absorption after benzamil
addition, TER values for individual CF and non-CF cell
cultures (made using a volt-ohm meter), DTPA absorp-
tion rates with and without apical mannitol, and
measurements of TER with Ringer’s vs. Ringer’s + man-
nitol (by Ussing chamber) were also performed by un-
paired t test. Linear regression was utilized to
determine the relationship between DTPA absorption
and liquid absorption (Stata 12, Stata Corp., College
Station, TX, USA). For regressions, values for R2 are
presented along with associated p values. All values
presented in the text are ±standard deviation (SD) un-
less otherwise indicated. Error bars in figures are
±standard error of the mean (SEM) unless otherwise
indicated.Results
DTPA absorption rates in CF and non-CF HBE cell cultures
To determine whether DTPA absorption is different in
CF primary airway cells compared to non-CF cells, the
retention of DTPA on the apical surface was measured
over time. As shown in Figure 2, the mean DTPA ab-
sorption rate from the non-CF cell lines was 30.1 ±
8.4%/24 h (11 lines, six cultures per line). The nine CF
cell lines absorbed DTPA on average at a significantly
higher rate, 56.4 ± 9.1%/24 h (±SD, p = 0.0013 by t test)
(CF cell line genotypes: 4 ΔF508/ΔF508, 2 ΔF508/
3659delC, 1 ΔF508/G85E, 1 ΔF508/P.11398S, 1 ΔF508/
unknown). Average values of ICl− were 17.5 ± 7.6 μA/
cm2 for the non-CF lines vs. 0.0 ± 0.5 μA/cm2 for the
CF lines (p < 0.0001); INa+, 32.8 ± 19.7 μA/cm
2 for non-
CF vs. 30.4 ± 30.2 μA/cm2 for CF (p = 0.83); and TER,
350 ± 162 μA/cm2 for non-CF vs. 476 ± 405 Ω cm2 for
CF (p = 0.36). Previous studies have demonstrated
increased rates of DTPA absorption in the airways of CF
subjects [14]. These studies provide in vitro corrobor-
ation of those results in a setting that excludes infection
and the associated inflammation as potential contribu-
tory causes.
Mixed-cell experiments
The mixing of CF and non-CF cells within individual
cultures provides a means of studying how the propor-
tional correction of CF pathophysiology affects epithelial
electrophysiology and liquid/DTPA absorption. Figure 3
includes measurements of INa+, ICl−, TER, and DTPA
and liquid absorption rates for a series of mixed-cell
Figure 3 Mixed-cell experiments and the relationship between
ICl−, INa+, TER, and DTPA and liquid absorption rates. Mixed-cell
HBE cultures were prepared including different proportions of CF
and non-CF cells (CF/non-CF): 100%:0%, 95%:5%, 90%:10%, 75%:25%,
50%:50%, and 0%:100%. Data shown are mean ICl−, INa+, percentage
of DTPA absorption at 24 h, and TER values.
Figure 4 DTPA absorption is proportional to liquid absorption
after volume addition. The figure compares the radioactive counts
of DTPA absorbed to apical liquid volume absorbed at six different
time points after the addition of 5 μL of Tc-DTPA in Ringer’s solution
(CF HBEs, six cultures included). Liquid volume was measured using
a previously described optical technique [22]. Each data point is
mean ± SEM. When repeated with different volumes, 2.5 μL:
R2 = 0.96, p = 0.003; 10 μL: R2 = 0.56, p = 0.09. When repeated in a
different CF cell line, 10 μL: R2 = 0.90, p = 0.004.
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higher proportions non-CF cells. Both DTPA and liquid
absorption decrease with ≥50% non-CF HBEs, following
similar patterns. INa+ was not correlated with the pro-
portion of CF vs. non-CF cells, DTPA absorption, or
ASL absorption. These results suggest that ICl− and TER
are the dominant determinants of ASL homeostasis
under these experimental conditions. The CF cell line
used in this experiment was ΔF508/P.11398S.
DTPA absorption after benzamil addition
In order to further consider the relationship between INa+
and DTPA absorption, we studied DTPA absorption after
the addition of 50 mM apical benzamil, a sodium channel
blocker vs. a Ringer’s control. DTPA absorption was similar
with Ringer’s vs. Ringer’s + benzamil in one CF (ΔF508/
3659delC) and one non-CF cell line (p = 0.49 and 1.0). Inan attempt to further enhance baseline liquid absorption
rates, large liquid volumes (~50 μL) were added to the ap-
ical surface of another set of cultures on the day prior to
measurements of DTPA absorption. DTPA absorption
rates with Ringer’s vs. Ringer’s + benzamil in these cells
were again similar (two different CF cell lines, both ΔF508/
3659delC), p = 0.26 and 0.38. Measurements were also
made in two non-CF lines. One result approached signifi-
cance (p = 0.06) with decreased DTPA absorption rates
associated with benzamil. The other result did not demon-
strate a significant difference (p = 0.27). This result
indicates that changes in INa+ do not influence DTPA ab-
sorption in this model.
Comparing DTPA and liquid absorption rates
Simultaneous measurements of DTPA absorption and
ASL volume were performed over a 24-h period after the
addition of 5 μL of Tc-DTPA to the apical surface of CF
HBEs (ΔF508/3659delC). The volume of liquid absorbed
was compared to the decay-corrected radioactive counts
of DTPA absorbed at the same time point. As Figure 4
demonstrates, there was a linear relationship between the
amounts of DTPA and liquid absorbed throughout the
24-h test period (R2 = 0.990, p < 0.001). Studies after the
addition of 2.5 μL to this cell line demonstrated similar
correlations (R2 = 0.96, p = 0.003). Studies after the
addition of 10 μL demonstrated correlation but only
approached statistical significance (R2 = 0.56, p = 0.09).
A study in a different CF cell line (ΔF508/P.11398S) with
a 10-μL volume demonstrated significant correlation
(R2 = 0.90, p = 0.004).
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The measurement of electrical resistance across the air-
way epithelium is a useful gauge of barrier integrity and
tight junction permeability. Previous studies have
demonstrated decreased TER in CF epithelial cells [26],
so here we sought to determine whether increased DTPA
absorption in the CF airway was associated with lower
TER and increased tight junction permeability. Figure 5
compares DTPA absorption to TER as measured in indi-
vidual cell cultures on the day prior to DTPA absorption
measurements, using a volt-ohm meter. The average TER
was 312 ± 156 and 130 ± 42 Ω cm2 for the non-CF (four
cell lines, n = 30) and CF (one cell line, n = 12, ΔF508/
ΔF508) cells, respectively (p < 0.001 by t test). These
results indicate significantly lower TER in the CF cells. No
relationship between TER and DTPA absorption rate is
apparent across an extensive range of TER values. Exam-
ining CF and non-CF cultures with TER < 200 Ω also
reveals that Tc-DTPA absorption is significantly increased
in CF cells (n = 12) compared to non-CF cells (n = 8) with
similar TER levels (p < 0.0001). These results do not ex-
clude a role for tight junction permeability in determining
DTPA absorption rate, but they indicate that it is likely
not the sole cause of the difference between the CF and
non-CF cell lines noted here.The effects of volume addition on DTPA and liquid
absorption
Adding liquid volume to the apical surface of HBE cells
has been shown to provide a stimulus for liquid absorp-
tion [23]. Figure 6 illustrates that both DTPA and liquid
absorption rates increase linearly with added liquid vol-
ume. These results indicate a dominant role of liquidFigure 5 There is no appreciable correlation between
transepithelial resistance and DTPA absorption rate.
Measurements of TER from individual cell cultures were made using
a volt-ohm meter 24 h prior to the addition of 10 μL of Tc-DTPA in
PBS; one CF line (n = 12) and four non-CF lines (n = 30).absorption in determining DTPA absorption rate in this
model.DTPA absorption under varying osmotic gradients
To further address the hypothesis that DTPA absorption
is directly related to transepithelial liquid movement, os-
motic gradients were created to alter liquid movement.
Mannitol addition to the basolateral surface of the HBE
cultures creates an osmotic gradient favoring liquid ab-
sorption. As shown in Figure 7, DTPA absorption rate
increased linearly with basolateral mannitol concen-
tration in both CF and non-CF cells, demonstrating a
relationship between liquid absorption and DTPA ab-
sorption. Two CF (ΔF508/ΔF508, ΔF508/D1152H) and
two non-CF cell lines were included. The addition of
300mM apical mannitol, which creates the opposite os-
motic gradient, significantly slowed DTPA absorption vs.
baseline in CF cells (23.8 ± 10.3%/24 h vs. 41.5 ± 9.1%/
24 h; p < 0.0001). Previous studies in 16HBE14o- cells
demonstrated decreases in TER in response to apical
mannitol [27]. To determine whether such changes
might play a role in DTPA absorption results, we
performed Ussing chamber measurements of TER in
non-CF HBEs after the addition of 300 mM mannitol to
the apical surface. These studies demonstrated an effect
opposite to that previously described. TER increased in
response to apical mannitol (baseline TER = 388 ± 93 vs.
622 ± 215 Ω cm2, ±SD, p < 0.001 by t test). This
indicates that the alterations in DTPA absorption were
not the result of changes in tight junction permeability
after mannitol addition.Figure 6 Liquid and DTPA absorption rates increase linearly
with added liquid volume. Volumes of 2.5, 5, and 10 μL of
Tc-DTPA in Ringer’s solution were added to the apical surface of CF
HBE cells (one line, six filters per volume), and both DTPA and liquid
absorption were measured over 24 h. Each data point is mean
± SEM.
Figure 7 DTPA absorption is driven by osmotic gradients
across the airway epithelium. DTPA absorption rates were
measured in two CF and two non-CF cell lines (n = 6 per
concentration per line) under increasing basolateral mannitol
concentrations. Each data point is mean ± SEM. Measurements were
made after the addition of 10 μL of Tc-DTPA in PBS. Figure 8 DTPA absorption in the cystic fibrosis airway is
normalized by an apical osmotic gradient. Apical DTPA
absorption was measured in untreated CF epithelial cells and cells
with 300 mM mannitol added to the apical surface (three CF cell
lines, n = 6 cultures per line). Average data from seven non-CF lines
presented for comparison purposes. Asterisk, p < 0.0001, comparing
CF with treated CF. Each data point is mean ± SEM.
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mannitol
Mannitol is currently utilized as an inhaled therapy for
CF on the premise that the osmotic gradients created
after its deposition in the airways will result in liquid
transport from the epithelium into the airway lumen, hy-
drating secretions and improving mucociliary clearance
[25]. As Figure 8 demonstrates, the addition of mannitol
to the apical (luminal) surface of the airway epithelium
decreases DTPA absorption in CF airway cells (ΔF508/
3659delC). This result highlights the relative magnitude
of DTPA absorption response compared to baseline
measurements in CF and non-CF HBE cultures, and per-
haps more importantly, supports the use of DTPA ab-
sorption as a marker of liquid movement for therapeutic
interventions directed at altering liquid absorption in
human airway epithelia.
Discussion
Liquid transport through the airway epithelium can
occur through transcellular and paracellular routes.
Rate-limiting ion transport and transmembrane water
flux occur through specific ion and aquaporin channels
in the cell membrane which restrict the passage of most
solutes. Paracellular transport occurs through the tight
junctions which are more permeable to small molecule
solutes. Transcellular routes are thought to provide the
dominant path for liquid absorption based on substantial
changes in epithelial cell height observed during apical
liquid absorption; however, the relative contributions of
these routes have not been definitively determined [21].
Both diffusion and liquid flux may contribute to the
paracellular transport of small solutes through the epi-
thelium [19], and a variety of factors related to either orboth mechanisms could affect the solute transport rate.
A small radiolabeled solute could be used to indicate air-
way liquid absorption if paracellular liquid flux was sig-
nificant and proportional to total absorption and if its
effect on solute transport was sufficient to allow for
measurement. The inhalation of the solute in a liquid
aerosol would provide epithelial delivery of both the sol-
ute and the liquid volume required to stimulate absorp-
tion. Radiolabeled DTPA is a good candidate as a solute
in this role based on its safety history and availability.
DTPA absorption from the lung has received extensive
study, typically as an assessment of whole-lung perme-
ability, and increased DTPA absorption rates have been
associated with alveolar damage or increased tight junc-
tion permeability resulting from pro-inflammatory stim-
uli. Our previous studies have demonstrated increased
rates of DTPA absorption in the airway-dominated cen-
tral lung zones of individuals with CF compared to
healthy controls [14]. Potential sources of this increased
absorption include epithelial damage [16], inflammation-
associated increases in tight junction permeability [15],
specific effects of CFTR within tight junctions [28,29],
and the hyper-absorption of liquid by the epithelium.
Lower airway surface liquid volumes in CF could also re-
sult in increased concentrations of DTPA in the ASL,
potentially contributing to higher rates of concentration-
driven diffusion across the epithelium [30].
Here we have used in vitro models to better determine
whether liquid absorption contributes significantly to
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vide a mechanistic basis for designing a functional im-
aging method for detecting changes in airway liquid
absorption. CF airway cultures absorbed DTPA at a sig-
nificantly higher rate than non-CF cells, matching the
trends of our previous in vivo studies. CF airway cultures
accurately depict the basic ion transport defects of CF
and have been previously shown to hyper-absorb liquid
[21]. The epithelial damage that can occur in CF and the
pro-inflammatory cytokines associated with infection are
not present in this model, though some studies suggest
that increased baseline levels of pro-inflammatory
cytokines are present in CF HBEs [31,32].
Increased Na+ absorption by ENaC has been described
as a contributory mechanism driving airway liquid
hyper-absorption in the CF airway along with decreased
Cl− secretion [2,6,24]. However, a recent study failed to
demonstrate differences in Na+ absorption between CF
and non-CF epithelia [3]. The addition of the long-
acting sodium channel blocker benzamil did not affect
DTPA absorption rates in our experiments. Our mixed-
cell studies demonstrated proportional increases in ICl−
and TER and decreases in DTPA and liquid absorption
as non-CF HBEs were added to CF HBEs. INa+ did not
demonstrate a specific trend with cell type in these
experiments. Therefore, ENaC-mediated sodium absorp-
tion did not significantly influence liquid or DTPA ab-
sorption in this specific model.
A linear relationship between DTPA and liquid ab-
sorption rates was demonstrated after apical liquid
addition to CF HBE cultures. Likely, some portion of
this absorption is paracellular, and DTPA is simply
conveyed along with liquid flow through the tight
junctions between epithelial cells. This result implies
that the paracellular movement of DTPA is proportional
to the overall liquid absorption by the epithelium when
a stimulus for liquid absorption is applied. TER, which
provides a means of quantifying tight junction perme-
ability, was lower in the CF cultures when assessed with
a volt-ohm meter. There was no relationship between
TER and DTPA absorption rate across a large range of
TER values, and the DTPA absorption rate was still sig-
nificantly higher in CF cultures when compared to non-
CF cultures with similar TER levels. This result implies
that DTPA absorption in these experiments is being
driven by factors not directly related to epithelial dam-
age or tight junction permeability. In a setting where no
stimulus for liquid absorption is applied, these factors
are more likely to influence DTPA absorption rate. TER
values increased with the proportion of non-CF cells
added to our mixed-cell experiments; however, there
was no difference in TER when representative
measurements from 9 CF and 11 non-CF cell lines were
compared.Both liquid and DTPA absorption rates increased
linearly with liquid volume added to the apical surface of
CF HBEs. Previous studies have demonstrated propor-
tional increases in ENaC activity in response to apical fluid
addition which provides a stimulus for higher rates of li-
quid absorption [24]. Though we did not demonstrate a
relationship between baseline INa+ and DTPA absorption,
it is likely that ENaC contributes to liquid absorption
when the ASL is expanded. A potential limitation of these
experiments is the relative dilution of the added Tc-DTPA
solutions by endogenous ASL fluid present in the cultures.
This endogenous fluid would have diluted smaller
volumes to a larger extent, thus resulting in higher DTPA
concentrations after the addition of higher volumes and
potentially affecting diffusion-related transport. Mannitol
was also utilized to modulate liquid flows through the epi-
thelium in order to demonstrate DTPA absorption re-
sponse. Basolateral mannitol addition in the HBE cultures
establishes an osmotic gradient favoring liquid absorption
from the apical (luminal) surface. Our experiments
demonstrated that DTPA absorption from the apical sur-
face increased in a dose-dependent manner when manni-
tol was added basolaterally. Previous studies have
indicated decreased TER in association with mannitol
[27], but our own Ussing chamber measurements did not
support this effect. Both of these experiments suggest that
DTPA may provide a surrogate marker for measuring air-
way liquid absorption; however, it is difficult to assess
whether the magnitude of the stimulation used in these
in vitro experiments is representative of stimuli affecting
airway liquid absorption in vivo. Such stimuli include the
inhalation of a liquid aerosol as previously described [14].
Finally, we considered the potential for DTPA absorp-
tion to be used as an indication of therapeutic efficacy.
Mannitol has been developed as an inhaled osmotic
therapy for use in CF under the premise that it will
cause liquid transport into the airway lumen that will
hydrate secretions and improve clearance [25]. For our
studies, 300 mM mannitol was applied apically along
with the Tc-DTPA. Apical mannitol decreased the DTPA
absorption rate of CF HBE cells by approximately 40%.
This provides an indication that DTPA absorption will
provide a robust measure of airway surface liquid modu-
lation in vivo. These data also support the validity of
DTPA absorption as an acute marker of transepithelial
liquid flux. In vivo mannitol dosing typically involves a
400-mg inhaled dose. Assuming 50% airway delivery and
dilution in 5 ml of ASL, that dose would provide ap-
proximately 200-mM mannitol concentrations in the
airways. Our dose is therefore of similar magnitude to
that used in the in vivo setting.
Limitations of the current study include the use of cell
culture models which replicate only the epithelial layer
of the airway and do not include the vasculature. Blood
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http://www.ejnmmires.com/content/3/1/14flow rate through the bronchial artery has been shown
to affect DTPA absorption from the airway in animal
models [18]. DTPA absorption occurred far more rapidly
in our previous in vivo studies vs. the current in vitro
studies (approximately 50%/h vs. 50%/24 h), indicating
the potential involvement of other rate-determining
factors. Airway cell cultures are the primary vehicle for
basic research and therapeutics development in CF in part
due to lack of a widely available animal model. In this
case, cell cultures provided the best option for relating the
basic pathophysiological effects of CF lung disease to the
results of our prior imaging studies; however, we cannot
assume that the physiological conditions in the cultures
are completely representative of in vivo conditions. After
the start of the experiment, no attempt was made to main-
tain set DTPA concentrations on the apical surface of the
HBE cultures. For this reason, we do not report data in
terms of permeability coefficient [33]. Mannitol concen-
tration was similarly allowed to fluctuate after the start of
the experiments. The basolateral media volume was sig-
nificantly larger than the apical volume (10× or more)
which would have largely negated the effects of basolateral
accumulation of DTPA or mannitol. The limitations of
our proposed use of DTPA absorption as an in vivo out-
come measure lie primarily in the number of factors that
could ultimately affect airway permeability to DTPA.
Our studies revealed no direct relationship between
TER and DTPA absorption rate in vitro, but these
experiments all included the application of apical liquid
volume which stimulates absorption. It is difficult to assess
how the magnitude of our in vitro stimuli may relate to
those exerted in vivo, and other factors involved in epithe-
lial permeability may contribute more substantially to the
determination of DTPA absorption rate in vivo. It is also
possible that different in vivo study techniques could be
designed to assess these factors individually.
Conclusions
Establishing a relationship between airway liquid
absorption and the absorption rate of an externally
detectable radiopharmaceutical would support the
development of a functional imaging method for
evaluating novel CF therapies. Such techniques could
provide for more rapid screening than is currently
available from existing outcome measures and
biomarkers. Radiolabeled DTPA is attractive for this
role based on its availability and safety history in the
lung; however, further experiments, particularly dem-
onstration that DTPA absorption reflects a thera-
peutic response in vivo, are needed to determine its
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